冠状动脉微血管功能障碍在心力衰竭的发病过程中的作用,其中保留了喷射分数
Becker Al-Khayatt1, Divaka Perera1, Haseeb Rahman1
1The British Heart Foundation Centre of Research Excellence, School of Cardiovascular Medicine and Sciences, King's College London, St Thomas' Hospital, Westminster Bridge Road, London SE1 7EH, United Kingdom.
概括
保存喷射分数 (HFpEF) 的心力衰竭是一个重要的健康问题. 冠状动脉微血管功能障碍 (CMD) 可能导致HFpEF,这表明了这种疾病的新治疗点.
科学领域:
- 心脏病学 心脏病学
- 心血管研究研究心血管研究
- 医学科学 医学科学 医学科学
背景情况:
- 由于有效治疗方法有限,心力衰竭与保留喷射分数 (HFpEF) 构成了医疗保健方面的重大挑战.
- 冠状动脉微血管功能障碍 (CMD),以冠状动脉血流调节受损为特征,越来越多地被认为是HFpEF的潜在贡献者.
- 冠状动脉疾病是非阻塞冠状动脉 (ANOCA) 中心痛的已知原因,在这些情况下,有针对性的治疗已经取得了成功.
研究的目的:
- 审查心脏微循环在健康心脏中的作用.
- 讨论微血管功能障碍如何可能导致HFpEF.
- 探索目前的CMD诊断方法,并确定未来的研究方向.
主要方法:
- 文献综述侧重于HFpEF和CMD的病理生理学.
- 分析用于评估冠状动脉微血管功能的诊断工具.
- 综合证据将CMD与HFpEF和ANOCA联系起来.
主要成果:
- 脑膜炎在HFpEF患者中普遍存在,并且可能代表特定的内型.
- 将CMD与HFpEF联系起来的病理生理学需要进一步阐明.
- 目前用于CMD的诊断工具正在不断发展,正在研究新的方法.
结论:
- CMD是HFpEF的一个合理的病因因子,提供了一个潜在的治疗点.
- 需要进一步的研究来证实因果关系,并开发有效的内型导向疗法,用于CMD驱动的HFpEF.
- 了解微循环的作用对于推进HFpEF治疗策略至关重要.
相关概念视频
01:17Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
01:26Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
01:29Pathophysiology of Cardiac Performance
644
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
644
01:17Ischemic Heart Disease: Overview
1.3K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K
01:22Heart Failure Drugs: Diuretics
370
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
370
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422